DEC 02, 2019 01:46 PM PST

What patients don't know: the side effects of cancer treatment

If anyone you know has ever had to go through treatment for cancer, or if you yourself have had to, you know that fighting the cancer is only part of the battle. Surgery, chemo, radiation, and immunotherapy may all help save lives, but the side effects of these cancer treatments can be debilitating, and new research shows that many patients feel blindsided by the severity of these effects.

The study was published recently in the Journal of Oncology Practice as an attempt to shed light on the fact that there are currently few statistics available to estimate what percentage of cancer patients will experience treatment side effects. The study surveyed 400 adults in the United States, all of whom had received cancer radiation therapy within the last 5 years. Of those 400 individuals, 52% had also had surgery and 41% of the participants had undergone chemotherapy.

The findings from the study showed that almost one-third of patients feel they lacked information on the possible side effects for all three cancer treatments. Common side effects for radiation and chemo include fatigue, hair loss, nausea and vomiting, changes in appetite and mood, and sleep problems. Chemo can also cause long-term heart or nerve damage as well as fertility issues.

The participants who had undergone more than one treatment also rated the severity of the side effects from 0 to 100, with chemotherapy coming out as the most severe at 63, surgery at 47, and radiation therapy at 45. Unsurprisingly, those who had undergone combination therapy also reported feeling more intense side effects of pain, weakness, and fatigue, than those who received radiation only.

Are cancer patients receiving all the information they need about potential side effects from treatment? Photo: The Conversation

"The pronounced impact of treatment side effects for patients receiving combination therapy also suggests a need to build better coordination between oncology disciplines about managing side effects and to improve informed consent processes across cancer therapies," commented first author Dr. Narek Shaverdian, who is a radiation oncologist at Memorial Sloan Kettering Cancer Center in New York City.

All in all, one in five of the participants reported wishing they had gotten more information about their treatment’s potential side effects. Whether that information is coming from their surgeons, their oncologists, their PCPs or cancer support groups, the consensus is in: cancer patients want to be better informed.

Sources: Medical News Today, Journal of Oncology Practice

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
DEC 14, 2019
Cancer
DEC 14, 2019
Treating glioblastomas through the bloodstream
New research published in Nature Communications details a novel immunotherapy that is capable of treating brain cancer via the bloodstream. Although only p...
DEC 14, 2019
Cardiology
DEC 14, 2019
Exercise Produces Greater Benefits In Those With Cardiovascular Disease
The fact that exercise benefits the heart and can help a person live a longer healthier life is well established. Exercising regularly can improve quality...
DEC 14, 2019
Cancer
DEC 14, 2019
Detecting breast cancer in men
New research published recently in the journal Radiology suggests the need for improved mammography screening for men who are at high risk for breast cance...
DEC 14, 2019
Cell & Molecular Biology
DEC 14, 2019
Discovery of Novel Biomarker for Lung Cancer Could Improve Survival
A molecular biomarker is discovered that improves diagnosing lung cancer and specializing treatment....
DEC 14, 2019
Cancer
DEC 14, 2019
Hair follicles: an origin point for melanoma
As far as skin cancers go, advanced invasive melanoma is quite aggressive – treatment options are still lacking effectiveness. Even though it is quit...
DEC 14, 2019
Drug Discovery & Development
DEC 14, 2019
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
Loading Comments...